QUILT 2.023: A Study of N-803 in Combination With Current Standard of Care vs Standard of Care as First-Line Treatment for Patients With Stage 3 or 4 NSCLC.

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/04 → 1/1/24

Funding

  • ImmunityBio